Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (65)

41

Role of bridging therapy during chimeric antigen receptor T cell therapy

enthalten in: eJHaem | 2022

von Bhaskar, S. | Dholaria, B. | Sengsayadeth, S. | +2

42

Chimeric antigen receptor‐T cell therapies : The changing landscape

enthalten in: eJHaem | 2022

von Sengsayadeth, S. | Dholaria, B. | Savani, B. | +1

43

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma

enthalten in: Blood advances | 2021

von Neelapu, S. | Locke, F. | Bartlett, N. | +16

44

Clinical experience of CAR T cell therapy in lymphomas

enthalten in: Best practice & research. Clinical haematology | 2021

von Oluwole, O.

45

Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma

enthalten in: British journal of haematology | 2021

von Oluwole, O. | Bouabdallah, K. | Muñoz, J. | +24

CommentIn: Br J Haematol. 2021 Aug;194(4):659-660. - PMID 34296425

46

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia : phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

enthalten in: Lancet (London, England) | 2021

von Shah, B. | Ghobadi, A. | Oluwole, O. | +28

CommentIn: Lancet. 2021 Aug 7;398(10299):466-467. - PMID 34097851

47

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia : ZUMA-3 phase 1 results

enthalten in: Blood | 2021

von Shah, B. | Bishop, M. | Oluwole, O. | +24

48

Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies

enthalten in: Circulation research | 2021

von Baik, A. | Oluwole, O. | Johnson, D. | +4

49

Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response

enthalten in: Immunity | 2021

von Levine, L. | Hiam-Galvez, K. | Marquez, D. | +8

CommentIn: Immunity. 2021 Apr 13;54(4):610-613. - PMID 33852827

50

Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States

enthalten in: Journal of medical economics | 2021

von Liu, R. | Oluwole, O. | Diakite, I. | +3